Terapia del diabete, dieta e farmaci (megatrials e meta-analisi)

Angelo CignarelliMarella MarassiGiovanni Antonio Silverii

A cura di Angelo Cignarelli, Marella Marassi e Giovanni Antonio Silverii

Maggio
22
2026
SURPASS-CVOT: duello tirzepatide versus dulaglutide sugli outcome cardiovascolari nel T2DM - Cardiovascular Outcomes with Tirzepatide versus Dulaglutide in Type 2 Diabetes
A cura di Angelo Cignarelli, Marella Marassi, Giovanni Antonio Silverii

Gennaio
23
2026
Educazione terapeutica domiciliare nel diabete erogata da paramedici di comunità: risultati di uno studio pilota pragmatico - Pilot Pragmatic Trial of a Community Paramedic Diabetes Self-Management Education Program for Adults With Diabetes
A cura di Elisa Cipponeri, Natalia Piana, Guglielmo Beccuti

Dicembre
19
2025
Efficacia dell’associazione Cagrilintide-semaglutide su compenso glicemico e perdita di peso nel diabete mellito di tipo2 - Cagrilintide–Semaglutide in Adults with Overweight or Obesity and Type 2 Diabetes
A cura di Giovanni Antonio Silverii, Marella Marassi, Angelo Cignarelli

Luglio
18
2025
Finerenone e Empagliflozin nella malattia renale cronica e diabete tipo 2 - Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes
A cura di Marella Marassi, Giovanni Antonio Silverii, Angelo Cignarelli

Marzo
22
2025
SGLT2i, amputazioni e rivascolarizzazioni periferiche: il rischio è reale e rilevante o è una coincidenza? - Use of SGLT2i Versus DPP-4i as an Add-on Therapy and the Risk of PAD-Related Surgical Events (Amputation, Stent Placement, or Vascular Surgery): A Cohort Study in Veterans With Diabetes
A cura di Mario Luca Morieri, Ilaria Dicembrini

Febbraio
22
2025
Agonisti del recettore GLP-1 e riduzione del peso: conferme e nuovi spunti dalle meta-analisi - Efficacy of GLP-1 Receptor Agonists on Weight Loss, BMI, and Waist Circumference for Patients With Obesity or Overweight: A Systematic Review, Meta-analysis, and Meta-regression of 47 Randomized Controlled Trials
A cura di Ilaria Dicembrini, Mario Luca Morieri

Gennaio
25
2025
SGLT2i nel paziente ospedalizzato? I vantaggi ci sono, ma anche i rischi non vanno dimenticati! - A Systematic Review and Meta-analysis on the Safety and Efficacy of Sodium-Glucose Cotransporter 2 Inhibitor Use in Hospitalized Patients
A cura di Mario Luca Morieri, Ilaria Dicembrini

Dicembre
28
2024
L’insulino-resistenza non risparmia nessuno. Influenze cardiovascolari e fatali nel diabete tipo 1 - Association of Insulin Resistance With Cardiovascular Disease and All-Cause Mortality in Type 1 Diabetes: Systematic Review and Meta-analysis
A cura di Ilaria Dicembrini, Mario Luca Morieri

Novembre
30
2024
Comparative effectiveness of sodium-glucose cotransporter-2 inhibitors for recurrent nephrolithiasis among patients with pre-existing nephrolithiasis or gout: target trial emulation studies
A cura di Mario Luca Morieri, Ilaria Dicembrini

Aprile
20
2024
Phenotype-based targeted treatment of SGLT2 inhibitors and GLP-1 receptor agonists in type 2 diabetes
A cura di Ilaria Dicembrini, Mario Luca Morieri

Marzo
26
2024
Association of glycaemic index and glycaemic load with type 2 diabetes, cardiovascular disease, cancer, and all-cause mortality: a meta-analysis of mega cohorts of more than 100 000 participants
A cura di Ilaria Dicembrini, Mario Luca Morieri

Marzo
23
2024
Association between baseline glycated hemoglobin level and atrial fibrillation recurrence following cryoballoon ablation among patients with and without diabetes
A cura di Raffaele Galiero

Febbraio
24
2024
Hypoglycemia and Cardiovascular Outcomes in the CARMELINA and CAROLINA Trials of Linagliptin: A Secondary Analysis of Randomized Clinical Trials
A cura di Mario Luca Morieri, Ilaria Dicembrini

Gennaio
27
2024
Effects of mHealth-Based Lifestyle Interventions on Gestational Diabetes Mellitus in Pregnant Women With Overweight and Obesity: Systematic Review and Meta-Analysis
A cura di Ilaria Dicembrini, Mario Luca Morieri

Dicembre
30
2023
Impact of Finerenone-Induced Albuminuria Reduction on Chronic Kidney Disease Outcomes in Type 2 Diabetes : A Mediation Analysis
A cura di Mario Luca Morieri, Ilaria Dicembrini

Dicembre
02
2023
C-peptide and metabolic outcomes in trials of disease modifying therapy in new-onset type 1 diabetes: an individual participant meta-analysis
A cura di Ilaria Dicembrini, Mario Luca Morieri

Novembre
04
2023
Pharmacogenomics of GLP-1 receptor agonists: a genome-wide analysis of observational data and large randomised controlled trials
A cura di Mario Luca Morieri, Ilaria Dicembrini

Ottobre
07
2023
Benefits and harms of drug treatment for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials
A cura di Ilaria Dicembrini, Mario Luca Morieri

Settembre
09
2023
The Impact of Neighborhoods on Diabetes Risk and Outcomes: Centering Health Equity
A cura di Mario Luca Morieri, Ilaria Dicembrini

Agosto
12
2023
Genome-wide association analysis identifies ancestry-specific genetic variation associated with acute response to metformin and glipizide in SUGAR-MGH
A cura di Mario Luca Morieri, Ilaria Dicembrini

Luglio
15
2023
Influenza: Diabetes as a risk factor for severe related-outcomes and the effectiveness of vaccination in diabetic population. A meta-analysis of observational studies
A cura di Ilaria Dicembrini, Mario Luca Morieri

Giugno
17
2023
Use of non-sugar sweeteners: WHO guideline
A cura di Ilaria Dicembrini, Mario Luca Morieri

Maggio
20
2023
Effect of Financial Incentives and Default Options on Food Choices of Adults With Low Income in Online Retail Settings: A Randomized Clinical Trial
A cura di Ilaria Dicembrini, Mario Luca Morieri

Aprile
22
2023
Comparison of seven popular structured dietary programmes and risk of mortality and major cardiovascular events in patients at increased cardiovascular risk: systematic review and network meta-analysis
A cura di Ilaria Dicembrini, Mario Luca Morieri

Marzo
25
2023
What is the impact of vitamin D supplementation on glycemic control in people with type-2 diabetes: a systematic review and meta-analysis of randomized controlled trials
A cura di Ilaria Dicembrini, Mario Luca Morieri

Febbraio
25
2023
Patient preference for second- and third-line therapies in type 2 diabetes: a prespecified secondary endpoint of the TriMaster study
A cura di Mario Luca Morieri, Ilaria Dicembrini

Gennaio
28
2023
Patient stratification for determining optimal second-line and third-line therapy for type 2 diabetes: the TriMaster study
A cura di Ilaria Dicembrini, Mario Luca Morieri

Dicembre
31
2022
Association of COVID-19 with diabetes: a systematic review and meta-analysis
A cura di Mario Luca Morieri, Ilaria Dicembrini

Dicembre
03
2022
Nordic dietary patterns and cardiometabolic outcomes: a systematic review and meta-analysis of prospective cohort studies and randomised controlled trials
A cura di Mario Luca Morieri, Ilaria Dicembrini

Novembre
05
2022
Association of gestational diabetes mellitus with overall and type specific cardiovascular and cerebrovascular diseases: systematic review and meta-analysis
A cura di Ilaria Dicembrini, Mario Luca Morieri

Ottobre
08
2022
Association of Glucagon-Like Peptide-1 Receptor Agonist Use With Risk of Gallbladder and Biliary Diseases: A Systematic Review and Meta-analysis of Randomized Clinical Trials
A cura di Ilaria Dicembrini, Mario Luca Morieri

Settembre
10
2022
Relation of Change or Substitution of Low- and No-Calorie Sweetened Beverages With Cardiometabolic Outcomes: A Systematic Review and Meta-analysis of Prospective Cohort Studies
A cura di Mario Luca Morieri, Ilaria Dicembrini

Settembre
10
2022
Relation of Change or Substitution of Low- and No-Calorie Sweetened Beverages With Cardiometabolic Outcomes: A Systematic Review and Meta-analysis of Prospective Cohort Studies
A cura di Mario Luca Morieri, Ilaria Dicembrini

Agosto
13
2022
Cardiovascular Outcomes in Patients Initiating First-Line Treatment of Type 2 Diabetes With Sodium-Glucose Cotransporter-2 Inhibitors Versus Metformin: A Cohort Study
A cura di Mario Luca Morieri, Ilaria Dicembrini

Luglio
16
2022
Anthropometric and adiposity indicators and risk of type 2 diabetes: systematic review and dose-response meta-analysis of cohort studies
A cura di Ilaria Dicembrini, Mario Luca Morieri

Giugno
18
2022
Once-Weekly Dulaglutide for the Treatment of Youths with Type 2 Diabetes
A cura di Ilaria Dicembrini, Mario Luca Morieri

Maggio
21
2022
Comparison between different types of exercise training in patients with type 2 diabetes mellitus: A systematic review and network metanalysis of randomized controlled trials
A cura di Mario Luca Morieri, Ilaria Dicembrini

Aprile
23
2022
Tirzepatide cardiovascular event risk assessment: a pre-specified meta-analysis
A cura di Mario Luca Morieri, Ilaria Dicembrini

Marzo
26
2022
Real-world evidence on clinical outcomes of people with type 1 diabetes using open-source and commercial automated insulin dosing systems: A systematic review
A cura di Ilaria Dicembrini, Mario Luca Morieri

Febbraio
26
2022
Self-management in patients with type 2 diabetes: Group-based versus individual education. A systematic review with meta-analysis of randomized trails
A cura di Mario Luca Morieri, Ilaria Dicembrini

Gennaio
29
2022
Population stratification in type 2 diabetes mellitus: A systematic review
A cura di Mario Luca Morieri, Ilaria Dicembrini

Gennaio
01
2022
Blood Pressure Lowering Treatment Trialists’ Collaboration. Blood pressure lowering and risk of new-onset type 2 diabetes: an individual participant data meta-analysis
A cura di Mario Luca Morieri, Ilaria Dicembrini

Dicembre
04
2021
Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials
A cura di Mario Luca Morieri, Ilaria Dicembrini

Novembre
06
2021
Sodium–Glucose Cotransporter-2 Inhibitors Versus Glucagon-like Peptide-1 Receptor Agonists and the Risk for Cardiovascular Outcomes in Routine Care Patients With Diabetes Across Categories of Cardiovascular Disease
A cura di Ilaria Dicembrini, Mario Luca Morieri

Ottobre
09
2021
Hypo-RESOLVE consortium. Changes in Quality of Life Following Hypoglycaemia in Adults with Type 2 Diabetes: A Systematic Review of Longitudinal Studies
A cura di Ilaria Dicembrini, Mario Luca Morieri

Settembre
11
2021
Association of metabolic-bariatric surgery with long-term survival in adults with and without diabetes: a one-stage meta-analysis of matched cohort and prospective controlled studies with 174 772 participants
A cura di Mario Luca Morieri, Ilaria Dicembrini

Agosto
14
2021
Cardiovascular and Renal Outcomes with Efpeglenatide in Type 2 Diabetes
A cura di Mario Luca Morieri, Ilaria Dicembrini

Luglio
17
2021
Comparison of cardiovascular outcomes and cardiometabolic risk factors between patients with type 2 diabetes treated with sodium-glucose cotransporter-2 inhibitors and dipeptidyl peptidase-4 inhibitors: a meta-analysis
A cura di Mario Luca Morieri, Ilaria Dicembrini

Giugno
19
2021
Lower extremity reamputation in people with diabetes: a systematic review and meta-analysis
A cura di Mario Luca Morieri, Ilaria Dicembrini

Maggio
22
2021
Impact of high glucose levels and glucose lowering on risk of ischaemic stroke: a Mendelian randomisation study and meta-analysis
A cura di Mario Luca Morieri, Ilaria Dicembrini

Aprile
24
2021
Effect of metformin on all-cause mortality and major adverse cardiovascular events: An updated meta-analysis of randomized controlled trials
A cura di Ilaria Dicembrini, Mario Luca Morieri

Marzo
27
2021
Non-Insulin Antidiabetes Treatment in Type 1 Diabetes Mellitus: A Systematic Review and Meta-Analysis
A cura di Cristina Bianchi

Febbraio
27
2021
Meta-analysis of the effects of sodium glucose cotransporter 2 inhibitors in non-alcoholic fatty liver disease patients with type 2 diabetes
A cura di Matteo Monami

Gennaio
30
2021
Efficacy and Safety of Dulaglutide 3.0 mg and 4.5 mg Versus Dulaglutide 1.5 mg in Metformin-Treated Patients With Type 2 Diabetes in a Randomized Controlled Trial (AWARD-11)
A cura di Cristina Bianchi

Gennaio
02
2021
Risk of Cardiovascular Outcomes in Type 2 Diabetes Patients Following Addition of SGLT2 Inhibitors Versus Sulfonylureas to Baseline GLP-IRA Therapy
A cura di Matteo Monami

Dicembre
05
2020
Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes
A cura di Cristina Bianchi

Novembre
07
2020
Patients with diabetes mellitus and atrial fibrillation treated with NOACs: Meta-analysis of 8 outcomes in 58, 634 patients across 4 randomized controlled trials
A cura di Matteo Monami

Ottobre
10
2020
Dapagliflozin in Patients with Chronic Kidney Disease
A cura di Cristina Bianchi

Settembre
12
2020
Association between sodium-glucose cotransporter 2 (SGLT2) inhibitors and lower extremity amputation: A systematic review and meta-analysis
A cura di Matteo Monami

Luglio
18
2020
Metformin and risk of cancer among patients with type 2 diabetes mellitus: A systematic review and meta-analysis
A cura di Cristina Bianchi

Giugno
20
2020
Statin reduces the incidence of diabetic retinopathy and its need for intervention: A systematic review and meta-analysis
A cura di Matteo Monami

Maggio
23
2020
ACE Inhibitor Benefit to Kidney and Cardiovascular Outcomes for Patients with Non-Dialysis Chronic Kidney Disease Stages 3-5: A Network Meta-Analysis of Randomised Clinical Trials
A cura di Cristina Bianchi

Aprile
25
2020
Effectiveness of telemedicine for pregnant women with gestational diabetes mellitus: an updated meta-analysis of 32 randomized controlled trials with trial sequential analysis
A cura di Matteo Monami

Marzo
28
2020
Gender difference in Cardiovascular Outcomes with SGLT-2 inhibitors and GLP-1 receptor agonist in Type 2 Diabetes: A Systematic Review and Meta-analysis of Cardio-vascular Outcome Trials
A cura di Cristina Bianchi

Febbraio
29
2020
The effects of omega-3 fatty acids on diabetic nephropathy: A meta-analysis of randomized controlled trials
A cura di Matteo Monami

Febbraio
01
2020
Cardiovascular risk following metformin treatment in patients with type 2 diabetes mellitus: results from meta-analysis
A cura di Cristina Bianchi

Gennaio
04
2020
Associations between long-term exposure to ambient air pollution and risk of type 2 diabetes mellitus: A systematic review and meta-analysis
A cura di Matteo Monami

Dicembre
07
2019
Role of diet in type 2 diabetes incidence: umbrella review of meta-analyses of prospective observational studies
A cura di Cristina Bianchi

Novembre
09
2019
Decreased risk of Parkinson's disease in diabetic patients with thiazolidinediones therapy: An exploratory meta-analysis
A cura di Matteo Monami

Ottobre
12
2019
Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
A cura di Cristina Bianchi

Settembre
14
2019
Total sedentary behavior and TV viewing with risk of overweight/obesity, type 2 diabetes, and hypertension: a dose-response meta-analysis
A cura di Matteo Monami

Agosto
17
2019
Association between dairy intake and the risk of contracting type 2 diabetes and cardiovascular diseases: a systematic review and meta-analysis with subgroup analysis of men versus women
A cura di Cristina Bianchi

Luglio
20
2019
Mobile phone text messaging in improving glycaemic control for patients with type 2 diabetes mellitus: A systematic review and meta-analysis
A cura di Matteo Monami

Giugno
22
2019
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial
A cura di Cristina Bianchi

Maggio
25
2019
Efficacy and safety of dual SGLT 1/2 inhibitor sotagliflozin in type 1 diabetes: meta-analysis of randomised controlled trials
A cura di Matteo Monami

Aprile
27
2019
Non-high-density lipoprotein cholesterol and risk of cardiovascular disease in the general population and patients with type 2 diabetes: A systematic review and meta-analysis
A cura di Cristina Bianchi

Marzo
30
2019
Vaccines for the prevention of seasonal influenza in patients with diabetes: systematic review and meta-analysis
A cura di Matteo Monami

Marzo
02
2019
Aspirin for primary prevention of cardiovascular outcomes in diabetes mellitus: An updated systematic review and meta-analysis
A cura di Cristina Bianchi

Febbraio
02
2019
Mediterranean diet, cardiovascular disease and mortality in diabetes: A systematic review and meta-analysis of prospective cohort studies and randomized clinical trials
A cura di Matteo Monami

Gennaio
05
2019
The Renoprotective Effects of SGLT2 Inhibitors versus Placebo in Patients with Type 2 Diabetes with or without Prevalent Kidney Disease: A Systematic Review and Meta-analysis
A cura di Cristina Bianchi

Dicembre
08
2018
SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
A cura di Matteo Monami

Novembre
10
2018
Global Diabetes Prevention Interventions: A Systematic Review and Network Meta-analysis of the Real-World Impact on Incidence, Weight, and Glucose
A cura di Cristina Bianchi

Ottobre
13
2018
The Effects of Novel Antidiabetic Drugs on Albuminuria in Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis of Randomized Controlled Trials
A cura di Matteo Monami

Settembre
15
2018
Effectiveness of Internet-based interventions on glycemic control in patients with type 2 diabetes: Meta-analysis of randomized controlled trials
A cura di Giulio Marchesini

Agosto
18
2018
Contrast-induced nephropathy in patients with diabetes mellitus between iso- and low-osmolar contrast media: A meta-analysis of full-text prospective, randomized controlled trials
A cura di Matteo Monami

Luglio
21
2018
Type 2 diabetes in the real world: The elusive nature of glycemic control
A cura di Giulio Marchesini

Giugno
23
2018
Association Between Use of Sodium-Glucose Cotransporter 2 Inhibitors, Glucagon-like Peptide 1 Agonists, and Dipeptidyl Peptidase 4 Inhibitors With All-Cause Mortality in Patients With Type 2 Diabetes: A Systematic Review and Meta-analysis
A cura di Matteo Monami

Maggio
26
2018
Association between use of sodium-glucose cotransporter 2 inhibitors, glucagon-like peptide 1 agonists, and dipeptidyl peptidase 4 inhibitors with all-cause mortality in patients with type 2 diabetes: A systematic review and meta-analysis
A cura di Giulio Marchesini

Aprile
28
2018
Attending Diabetes Clinics is associated with a lower all-cause mortality. A meta-analysis of observational studies performed in Italy
A cura di Matteo Monami

Marzo
31
2018
Cardiovascular safety, long-term noncardiovascular safety, and efficacy of sodium-glucose cotransporter 2 inhibitors in patients with type 2 diabetes mellitus: A systemic review and meta-analysis with trial sequential analysis
A cura di Giulio Marchesini

Marzo
03
2018
Efficacy and safety of combination therapy with SGLT2 and DPP4 inhibitors in the treatment of type 2 diabetes: A systematic review and meta-analysis
A cura di Matteo Monami

Febbraio
03
2018
Environmental Risk Factors for Developing Type 2 Diabetes Mellitus: A Systematic Review
A cura di Giulio Marchesini

Gennaio
06
2018
Cardiovascular outcomes with glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes: a meta-analysis
A cura di Matteo Monami

Dicembre
09
2017
Nonnutritive sweeteners and cardiometabolic health: a systematic review and meta-analysis of randomized controlled trials and prospective cohort studies
A cura di Giulio Marchesini

Novembre
11
2017
PCSK9 monoclonal antibodies for the primary and secondary prevention of cardiovascular disease
A cura di Matteo Monami

Ottobre
14
2017
Coffee, caffeine, and health outcomes: an umbrella review
A cura di Giulio Marchesini

Settembre
16
2017
SGLT2 inhibitors and risk of cancer in type 2 diabetes: a systematic review and meta-analysis of randomised controlled trials
A cura di Matteo Monami

Agosto
19
2017
Incretin based treatments and mortality in patients with type 2 diabetes: systematic review and meta-analysis
A cura di Giulio Marchesini

Luglio
22
2017
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
A cura di Matteo Monami

Giugno
24
2017
Lower risk of heart failure and death in patients initiated on SGLT-2 inhibitors versus other glucose-lowering drugs: The CVD-REAL Study
A cura di Giulio Marchesini

Maggio
27
2017
Sodium Glucose Co-Transporter 2 (SGLT2) inhibitors and Fracture Risk in Patients with Type 2 Diabetes Mellitus: A Meta-Analysis
A cura di Matteo Monami

Aprile
29
2017
Thiazolidinediones and advanced liver fibrosis in nonalcoholic steatohepatitis: a meta-analysis
A cura di Giulio Marchesini

Aprile
01
2017
Insulin and Glucagon-Like Peptide 1 Receptor Agonist Combination Therapy in Type 2 Diabetes: A Systematic Review and Meta-analysis of Randomized Controlled Trials
A cura di Matteo Monami

Marzo
04
2017
Pioglitazone and cardiovascular outcomes in patients with insulin resistance, pre-diabetes and type 2 diabetes: a systematic review and meta-analysis
A cura di Giulio Marchesini

Febbraio
04
2017
Relation of active, passive, and quitting smoking with incident diabetes: a meta-analysis and systematic review
A cura di Matteo Monami

Gennaio
07
2017
SGLT2 Inhibitor–associated Diabetic Ketoacidosis: Clinical Review and Recommendations for Prevention and Diagnosis
A cura di Giulio Marchesini

Dicembre
10
2016
Sodium-glucose co-transporter 2 inhibitors in addition to insulin therapy for management of type 2 diabetes mellitus: A meta-analysis of randomized controlled trials
A cura di Matteo Monami

Novembre
12
2016
A meta-analysis comparing clinical effects of short- or long-acting GLP-1receptor agonists versus insulin treatment from head-to-head studies in type 2 diabetic patients
A cura di Giulio Marchesini

Ottobre
15
2016
Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
A cura di Matteo Monami

Settembre
17
2016
Association between diabetes and risk of suicide death: A meta-analysis of 3 million participants
A cura di Giulio Marchesini

Agosto
20
2016
Effects of sodium-glucose cotransporter-2 inhibitors on cardiovascular events, death, and major safety outcomes in adults with type 2 diabetes: a systematic review and meta-analysis
A cura di Matteo Monami

Luglio
23
2016
Intensive treatment and severe hypoglycemia among adults with type 2 diabetes
A cura di Giulio Marchesini

Giugno
25
2016
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
A cura di Matteo Monami

Maggio
07
2016
Diabetes Medications as Monotherapy or Metformin-Based Combination Therapy for Type 2 Diabetes: A Systematic Review and Meta-analysis
A cura di Giulio Marchesini

Aprile
09
2016
Pioglitazone after Ischemic Stroke or Transient Ischemic Attack
A cura di Giulio Marchesini

Marzo
12
2016
Dipeptidyl peptidase-4 inhibitors and risk of heart failure in type 2 diabetes: systematic review and meta-analysis of randomised and observational studies
A cura di Giulio Marchesini

Febbraio
13
2016
Mental Health Conditions Among Patients Seeking and Undergoing Bariatric Surgery A Meta-analysis
A cura di Giulio Marchesini

Gennaio
16
2016
Benefits and Harms of Once-Weekly Glucagon-like Peptide-1 Receptor Agonist Treatments: A Systematic Review and Network Meta-analysis
A cura di Giulio Marchesini

Dicembre
19
2015
Behavioral Programs for Type 2 Diabetes Mellitus. A Systematic Review and Network Meta-analysis
A cura di Giulio Marchesini

Novembre
21
2015
Excess Mortality among Persons with Type 2 Diabetes
A cura di Giulio Marchesini

Ottobre
24
2015
Empagliflozin, Cardiovascular Outcomes and Mortality in Type 2 Diabetes
A cura di Giulio Marchesini

Settembre
26
2015
Patient-level meta-analysis of the EDITION 1, 2 and 3 studies: glycaemic control and hypoglycaemia with new insulin glargine 300 U/ml versus glargine 100 U/ml in people with type 2 diabetes
A cura di Giulio Marchesini

Agosto
29
2015
Incretin-based medications for type 2 diabetes: an overview of reviews
A cura di Giulio Marchesini

Agosto
01
2015
Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes
A cura di Giulio Marchesini

Luglio
04
2015
Once-weekly dulaglutide versus bedtime insulin glargine, both in combination with prandial insulin lispro, in patients with type 2 diabetes (AWARD-4): a randomised, open-label, phase 3, non-inferiority study
A cura di Giulio Marchesini

Giugno
06
2015
Drug-disease and drug-drug interactions: systematic examination of recommendations in 12 UK national clinical guidelines
A cura di Giulio Marchesini

Maggio
09
2015
Phosphodiesterase 5 Inhibitors for the Treatment of Erectile Dysfunction: A Trade-off Network Meta-analysis
A cura di Giulio Marchesini

Aprile
11
2015
Statin use reduces the risk of dementia in elderly patients: a nationwide data survey and propensity analysis
A cura di Giulio Marchesini

Marzo
14
2015
Effect of vitamin D supplementation on glycemic control in patients with type 2 diabetes: a systemic review of interventional studies
A cura di Giulio Marchesini

Febbraio
14
2015
Effects of high vs. low glycemic index of dietary carbohydrate on cardiovascular disease risk factors and insulin sensitivity: the OmniCarb randomized clinical trial
A cura di Giulio Marchesini

Gennaio
30
2015
Glycemic control and excess mortality in type 1 diabetes
A cura di Geremia B. Bolli

Gennaio
30
2015
Pharmacologic interventions for painful diabetic neuropathy: an umbrella systematic review and comparative effectiveness network meta-analysis - Painful diabetic neuropathy: many similarly effective therapies with widely dissimilar costs
A cura di Giulio Marchesini

Gennaio
30
2015
Long-term follow-up after bariatric surgery. A systematic review
A cura di Giulio Marchesini

Gennaio
30
2015
Mortalità a lungo termine nel Diabete di tipo 1: una “legacy” infinita? - A cura di Giulio Marchesini e Geremia Bolli
A cura di Giulio Marchesini, Geremia B. Bolli

Siditalia
Società Italiana di Diabetologia e delle Malattie del Metabolismo Ente del Terzo Settore
P. IVA 04394411005 C.F 80101700013

CONTATTI

+39 06.44240967
siditalia@siditalia.it
Via Pisa, 21 00162 Roma
World Obesity
Logic Solution
Copyright © 2023 SID ITALIA. Tutti i diritti riservati.